Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 48 Records) |
Query Trace: Cholangiocarcinoma and TP53[original query] |
---|
ARID1A alterations and their clinical significance in cholangiocarcinoma. PeerJ 2020 12 8 e10464. Namjan Achira, Techasen Anchalee, Loilome Watcharin, Sa-Ngaimwibool Prakasit, Jusakul Apin |
Association of TP53 Alteration with Tissue Specificity and Patient Outcome of IDH1-Mutant Glioma. Cells 2021 8 10 (8): . Murnyak Balazs, Huang L Er |
Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection. Clinical cancer research : an official journal of the American Association for Cancer Research 2021 5 27 (14): 4101-4108. Jolissaint Joshua S, Soares Kevin C, Seier Kenneth P, Kundra Ritika, Gönen Mithat, Shin Paul J, Boerner Thomas, Sigel Carlie, Madupuri Ramyasree, Vakiani Efsevia, Cercek Andrea, Harding James J, Kemeny Nancy E, Connell Louise C, Balachandran Vinod P, D'Angelica Michael I, Drebin Jeffrey A, Kingham T Peter, Wei Alice C, Jarnagin William |
Genetic Determinants of Outcome in Intrahepatic Cholangiocarcinoma. Hepatology (Baltimore, Md.) 2021 3 74 (3): 1429-1444. Boerner Thomas, Drill Esther, Pak Linda M, Nguyen Bastien, Sigel Carlie S, Doussot Alexandre, Shin Paul, Goldman Debra A, Gonen Mithat, Allen Peter J, Balachandran Vinod P, Cercek Andrea, Harding James, Solit David B, Schultz Nikolaus, Kundra Ritika, Walch Henry, D'Angelica Michael I, DeMatteo Ronald P, Drebin Jeffrey, Kemeny Nancy E, Kingham T Peter, Simpson Amber L, Hechtman Jaclyn F, Vakiani Efsevia, Lowery Maeve A, Ijzermans J N M, Buettner S, Koerkamp B Groot, Doukas M, Chandwani Rohit, Jarnagin William |
Mutational spectrum and precision oncology for biliary tract carcinoma. Theranostics 2021 3 11 (10): 4585-4598. Lin Jianzhen, Cao Yinghao, Yang Xu, Li Guangyu, Shi Yang, Wang Dongxu, Long Junyu, Song Yang, Mao Jinzhu, Xie Fucun, Bai Yi, Zhang Lei, Yang Xiaobo, Wan Xueshuai, Wang Anqiang, Guan Mei, Zhao Lin, Hu Ke, Pan Jie, Huo Li, Lu Xin, Mao Yilei, Sang Xinting, Zhang Henghui, Wang Kai, Wang Xiaoyue, Zhao Hait |
Clinically significant genomic alterations in the Chinese and Western patients with intrahepatic cholangiocarcinoma. BMC cancer 2021 Feb 21 (1): 152. Xu Shifeng, Guo Yuan, Zeng Yanwu, Song Zhijian, Zhu Xiaodan, Fan Ning, Zhang Zhilei, Ren Guibing, Zang Yunjin, Rao W |
Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. Journal of personalized medicine 2021 12 11 (12): . De Brian, Abu-Gheida Ibrahim, Patel Aashini, Ng Sylvia S W, Zaid Mohamed, Thunshelle Connor P, Elganainy Dalia, Corrigan Kelsey L, Rooney Michael K, Javle Milind, Raghav Kanwal, Lee Sunyoung S, Vauthey Jean-Nicolas, Tzeng Ching-Wei D, Tran Cao Hop S, Ludmir Ethan B, Minsky Bruce D, Smith Grace L, Holliday Emma B, Taniguchi Cullen M, Koong Albert C, Das Prajnan, Koay Eugene |
Prognosis of Advanced Cholangiocarcinoma in the Palliative Care Setting: A Series of 201 Cases. Alternative therapies in health and medicine 2021 Oct . Zeng Tianmei, Tao Chenjie, Yang Guang, Chen Xiyun, Yuan Zhenga |
Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients. International journal of clinical oncology 2021 Jan . Feng Feiling, Wu Xiaobing, Shi Xiaoliang, Gao Qingxiang, Wu Yue, Yu Yong, Cheng Qingbao, Li Bin, Yi Bin, Liu Chen, Hao Qing, Zhang Lin, Gao Chunfang, Jiang Xiaoqi |
Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study. Frontiers in oncology 2022 9 12 988527. Takada Kohichi, Kubo Tomohiro, Kikuchi Junko, Yoshida Makoto, Murota Ayako, Arihara Yohei, Nakamura Hajime, Nagashima Hiroyuki, Tanabe Hiroki, Sugita Shintaro, Tanaka Yumi, Miura Ayana, Ohhara Yoshihito, Ishiguro Atsushi, Yokouchi Hiroshi, Kawamoto Yasuyuki, Mizukami Yusuke, Ohnishi Hirofumi, Kinoshita Ichiro, Sakurai Akihi |
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis. Targeted oncology 2022 Sep 17 (5): 591-596. Rimini Margherita, Burgio Valentina, Antonuzzo Lorenzo, Rimassa Lorenza, Oneda Ester, Lavacchi Daniele, Personeni Nicola, Ratti Francesca, Pedica Federica, Della Corte Angelo, Persano Mara, De Cobelli Francesco, Aldrighetti Luca, Scartozzi Mario, Cascinu Stefano, Casadei-Gardini Andr |
Molecular characterization-based multi-omics analyses in primary liver cancer using the Japanese version of the genome atlas. Journal of hepato-biliary-pancreatic sciences 2022 8 . Imamura Taisuke, Okamura Yukiyasu, Ohshima Keiichi, Uesaka Katsuhiko, Sugiura Teiichi, Yamamoto Yusuke, Ashida Ryo, Ohgi Katsuhisa, Nagashima Takeshi, Yamaguchi K |
Genetic alterations during the neoplastic cascade towards cholangiocarcinoma in primary sclerosing cholangitis. The Journal of pathology 2022 Jul . Kamp Eline Jca, Dinjens Winand Nm, Doukas Michail, van Marion Ronald, Verheij Joanne, Ponsioen Cyriel Y, Bruno Marco J, Groot Koerkamp Bas, Trivedi Palak J, Peppelenbosch Maikel P, de Vries Annemarie |
Clinical, Genomic, and Transcriptomic Data Profiling of Biliary Tract Cancer Reveals Subtype-Specific Immune Signatures. JCO precision oncology 2022 6 6 e2100510. Mody Kabir, Jain Prerna, El-Refai Sherif M, Azad Nilofer S, Zabransky Daniel J, Baretti Marina, Shroff Rachna T, Kelley R Katie, El-Khouiery Anthony B, Hockenberry Adam J, Lau Denise, Lesinski Gregory B, Yarchoan Ma |
Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy. JCO precision oncology 2022 Jun 6 e2100274. Uson Junior Pedro Luiz Serrano, Majeed Umair, Yin Jun, Botrus Gehan, Sonbol Mohamad Bassam, Ahn Daniel H, Starr Jason S, Jones Jeremy C, Babiker Hani, Inabinett Samantha R, Wylie Natasha, Boyle Ashton W R, Bekaii-Saab Tanios S, Gores Gregory J, Smoot Rory, Barrett Michael, Nagalo Bolni, Meurice Nathalie, Elliott Natalie, Petit Joachim, Zhou Yumei, Arora Mansi, Dumbauld Chelsae, Barro Oumar, Baker Alexander, Bogenberger James, Buetow Kenneth, Mansfield Aaron, Mody Kabir, Borad Mitesh |
Mutation spectrum associated with metastasis of advanced cholangiocarcinoma. The Journal of international medical research 2022 Jun 50 (6): 3000605221102080. Song Hao, Huang Yao, Jiang Xiaoqi |
TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma. Frontiers in genetics 2022 4 13 844800. Guo Chunguang, Liu Zaoqu, Yu Yin, Chen Yunfang, Liu Hui, Guo Yaming, Peng Zhenyu, Cai Gaopo, Hua Zhaohui, Han Xinwei, Li Zh |
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer. Oncology 2022 Oct . Kim Hyera, Kim Jin Young, Park Keon |
Specific genomic alterations and prognostic analysis of perihilar cholangiocarcinoma and distal cholangiocarcinoma. Journal of gastrointestinal oncology 2021 Dec 12 (6): 2631-2642. Zheng Yuanwen, Qin Yejun, Gong Wei, Li Hongguang, Li Bin, Wang Yu, Chao Baoting, Zhao Shulei, Liu Luguang, Yao Shuzhan, Shi Junping, Shi Xiaoliang, Wang Kai, Xu Shife |
Circulating Cell-Free DNA-Based Comprehensive Molecular Analysis of Biliary Tract Cancers Using Next-Generation Sequencing. Cancers 2022 1 14 (1): . Csoma Szilvia Lilla, Bedekovics Judit, Veres Gerg?, Árokszállási Anita, András Csilla, Méhes Gábor, Mokánszki Atti |
Comprehensive analyses of the clinicopathological features and genomic mutations of combined hepatocellular-cholangiocarcinoma. Hepatology research : the official journal of the Japan Society of Hepatology 2023 9 . Takashi Ito, Takamichi Ishii, Haruhiko Takeda, Shinji Sumiyoshi, Katsuhiro Tomofuji, Satoshi Wakama, Kenta Makino, Hiroshi Horie, Ken Kumagai, Atsushi Takai, Elena Yukie Uebayashi, Satoshi Ogiso, Ken Fukumitsu, Hironori Haga, Hiroshi Seno, Etsuro Hata |
Development and validation of a mutation-annotated prognostic score (MAPS) for intrahepatic cholangiocarcinoma after resection: a retrospective cohort study. International journal of surgery (London, England) 2023 8 . Xiang-Yu Wang, Wen-Wei Zhu, Lu Lu, Yi-Tong Li, Ying Zhu, Lu-Yu Yang, Hao-Ting Sun, Chao-Qun Wang, Jing Lin, Chong Huang, Xin Yang, Jie Fan, Hu-Liang Jia, Ju-Bo Zhang, Bao-Bing Yin, Jin-Hong Chen, Lun-Xiu Q |
Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis. Open life sciences 2023 7 18 (1): 20220652. Jianbo Peng, Shuo Fang, Meisheng Li, Yuxin Liu, Xiaolu Liang, Zuobiao Li, Gaohui Chen, Lijiao Peng, Nianping Chen, Lei Liu, Xiaohong Xu, Wei D |
Updated survival outcomes with ivosidenib in patients with previously treated IDH1-mutated intrahepatic-cholangiocarcinoma: an Italian real-world experience. Therapeutic advances in medical oncology 2023 7 15 17588359231171574. Margherita Rimini, Valentina Burgio, Lorenzo Antonuzzo, Lorenza Rimassa, Ester Oneda, Caterina Soldà, Pasqua Cito, Guglielmo Nasti, Daniele Lavacchi, Valentina Zanuso, Mario Domenico Rizzato, Alberto Zaniboni, Alessandro Ottaiano, Mara Persano, Noemi Cornara, Mario Scartozzi, Stefano Cascinu, Andrea Casadei-Gardi |
ARID1A Mutation from Targeted NGS Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer. Cancer research and treatment 2023 5 . Sung Hwan Lee, Jaekyung Cheon, Seoyoung Lee, Beodeul Kang, Chan Kim, Hyo Sup Shim, Young Nyun Park, Sanghoon Jung, Sung Hoon Choi, Hye Jin Choi, Choong-Kun Lee, Hong Jae Ch |
Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma. World journal of surgical oncology 2023 3 21 (1): 90. Sun Bao-Ye, Yang Zhang-Fu, Wang Zhu-Tao, Liu Gao, Zhou Cheng, Zhou Jian, Fan Jia, Gan Wei, Yi Yong, Qiu Shuang-Ji |
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers. Nature communications 2023 2 14 (1): 630. Harding James J, Piha-Paul Sarina A, Shah Ronak H, Murphy Jessica J, Cleary James M, Shapiro Geoffrey I, Quinn David I, Braña Irene, Moreno Victor, Borad Mitesh, Loi Sherene, Spanggaard Iben, Park Haeseong, Ford James M, Arnedos Mónica, Stemmer Salomon M, de la Fouchardiere Christelle, Fountzilas Christos, Zhang Jie, DiPrimeo Daniel, Savin Casey, Duygu Selcuklu S, Berger Michael F, Eli Lisa D, Meric-Bernstam Funda, Jhaveri Komal, Solit David B, Abou-Alfa Ghassan |
Hepatic Sarcomatoid Carcinoma Is an Aggressive Hepatic Neoplasm Sharing Common Molecular Features With Its Conventional Carcinomatous Counterparts. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2023 2 36 (1): 100042. Yoshuantari Naomi, Jeng Yung-Ming, Liau Jau-Yu, Lee Chia-Hsiang, Tsai Jia-Hu |
Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis. Cancer immunology, immunotherapy : CII 2023 10 . Jiashuo Chao, Shanshan Wang, Hao Wang, Nan Zhang, Yunchao Wang, Xu Yang, Chengpei Zhu, Cong Ning, Xinmu Zhang, Jingnan Xue, Longhao Zhang, Mingjian Piao, Mingming Wang, Xiaobo Yang, Ling Lu, Haitao Zh |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: